WallStSmart

Ventas Inc (VTR)vsChiron Real Estate Inc. (XRN)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 4086% more annual revenue ($6.42B vs $153.35M). XRN leads profitability with a 37.8% profit margin vs 4.1%. VTR appears more attractively valued with a PEG of 4.94. XRN earns a higher WallStSmart Score of 58/100 (C).

VTR

Hold

41

out of 100

Grade: D

Growth: 6.0Profit: 4.5Value: 2.7Quality: 4.0
Piotroski: 4/9Altman Z: 0.43

XRN

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 5.7Quality: 6.0
Piotroski: 4/9Altman Z: -0.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VTROvervalued (-9.5%)

Margin of Safety

-9.5%

Fair Value

$76.70

Current Price

$82.04

$5.34 premium

UndervaluedFair: $76.70Overvalued

Intrinsic value data unavailable for XRN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VTR2 strengths · Avg: 8.0/10
Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

XRN4 strengths · Avg: 9.5/10
P/E RatioValuation
9.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Profit MarginProfitability
37.8%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
23.2%8/10

Strong operational efficiency at 23.2%

Areas to Watch

VTR4 concerns · Avg: 2.5/10
Return on EquityProfitability
1.8%3/10

ROE of 1.8% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

PEG RatioValuation
4.942/10

Expensive relative to growth rate

P/E RatioValuation
152.8x2/10

Premium valuation, high expectations priced in

XRN4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.8%4/10

4.8% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$503.33M3/10

Smaller company, higher risk/reward

PEG RatioValuation
5.092/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : VTR

The strongest argument for VTR centers on Price/Book, Revenue Growth. Revenue growth of 21.7% demonstrates continued momentum.

Bull Case : XRN

The strongest argument for XRN centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 37.8% and operating margin at 23.2%.

Bear Case : VTR

The primary concerns for VTR are Return on Equity, Profit Margin, PEG Ratio. A P/E of 152.8x leaves little room for execution misses. Thin 4.1% margins leave little buffer for downturns.

Bear Case : XRN

The primary concerns for XRN are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

VTR profiles as a growth stock while XRN is a value play — different risk/reward profiles.

XRN carries more volatility with a beta of 1.13 — expect wider price swings.

VTR is growing revenue faster at 21.7% — sustainability is the question.

XRN generates stronger free cash flow (-231M), providing more financial flexibility.

Bottom Line

XRN scores higher overall (58/100 vs 41/100), backed by strong 37.8% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Chiron Real Estate Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Want to dig deeper into these stocks?